Huons wins IND approval for Phase 2 dry eye drug trial

Huons, a South Korean pharmaceutical company specializing in ophthalmic and injectable medicines, said Thursday it has received Investigational New Drug approval from the Ministry of Food and Drug Safety to begin a Phase 2 clinical trial of its dry eye treatment candidate.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.